EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice

Erika Dorochow iD, Nico Kraus iD, Nicolas Chenaux-Repond iD, Sandra Pierre, Anja Kolbinger iD, Gerd Geisslinger, Cristina Ortiz, Christoph Welsch iD, Jonel Trebicka, Robert Gurke iD, Lisa Hahnefeld iD, Sabine Klein und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Erika Dorochow und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, LOEWE Centre ACLF-I, Fraunhofer Cluster of Excellence for Immune-Mediated Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH) are the leading causes of liver disease worldwide. To identify disease-specific pathomechanisms, we analyzed the lipidome, metabolome and immune cell recruitment in livers in both diseases. Mice harboring ASH or NASH had comparable disease severities regarding mortality rate, neurological behavior, expression of fibrosis marker and albumin levels. Lipid droplet size was higher in NASH than ASH and qualitative differences in the lipidome were mainly based on incorporation of diet-specific fatty acids into triglycerides, phosphatidylcholines and lysophosphatidylcholines. Metabolomic analysis showed downregulated nucleoside levels in both models. Here, the corresponding uremic metabolites were only upregulated in NASH suggesting stronger cellular senescence, which was supported by lower antioxidant levels in NASH as compared to ASH. While altered urea cycle metabolites suggest increased nitric oxide synthesis in both models, in ASH, this depended on increased L-homoarginine levels indicating a cardiovascular response mechanism. Interestingly, only in NASH were the levels of tryptophan and its anti-inflammatory metabolite kynurenine upregulated. Fittingly, high-content immunohistochemistry showed a decreased macrophage recruitment and an increased polarization towards M2-like macrophages in NASH. In conclusion, with comparable disease severity in both models, higher lipid storage, oxidative stress and tryptophan/kynurenine levels were seen in NASH, leading to distinct immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsMiceLipidomicsKynurenineTryptophanLiverMetabolomicsFatty AcidsDisease Models, Animal

Stichwörter der Autor:innen

alcoholic fatty liver diseaselipid dropletslipidomicsmetabolomicsnon-alcoholic fatty liver disease

Substanzen

KynurenineTryptophanFatty Acids

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
  • Center for Internal Medicine, Hospital of the Goethe University Frankfurt, 60323 Frankfurt, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany.
  • Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, 60596 Frankfurt, Germany.
  • Clinic for Internal Medicine B, Hospital of the University of Münster, 48149 Münster, Germany.

ORCID-Profile: Erika Dorochow, Nico Kraus, Nicolas Chenaux-Repond, Anja Kolbinger, Christoph Welsch, Robert Gurke, Lisa Hahnefeld

Förderung

  • Deutsche Forschungsgemeinschaft
  • LOEWE Centre ACLF-I
  • Fraunhofer Cluster of Excellence for Immune-Mediated Diseases
  • German Research Foundation (DFG) EXC

Zitieren

APA

Dorochow, E., Kraus, N., Chenaux-Repond, N., Pierre, S., Kolbinger, A., Geisslinger, G., Ortiz, C., Welsch, C., Trebicka, J., Gurke, R., Hahnefeld, L., Klein, S., & Scholich, K. (2023). Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210351

Vancouver

Dorochow E, Kraus N, Chenaux-Repond N, Pierre S, Kolbinger A, Geisslinger G, et al. Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210351

BibTeX
@article{Dorochow2023,
  author = {Dorochow, Erika and Kraus, Nico and Chenaux-Repond, Nicolas and Pierre, Sandra and Kolbinger, Anja and Geisslinger, Gerd and Ortiz, Cristina and Welsch, Christoph and Trebicka, Jonel and Gurke, Robert and Hahnefeld, Lisa and Klein, Sabine and Scholich, Klaus},
  title = {Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210351}
}
Kostenlos starten →